Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Goodwill: 2016-2025

Historic Goodwill for Summit Therapeutics (SMMT) over the last 10 years, with Sep 2025 value amounting to $2.0 million.

  • Summit Therapeutics' Goodwill rose 0.40% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 0.40%. This contributed to the annual value of $1.9 million for FY2024, which is 1.53% down from last year.
  • Per Summit Therapeutics' latest filing, its Goodwill stood at $2.0 million for Q3 2025, which was down 1.96% from $2.0 million recorded in Q2 2025.
  • Summit Therapeutics' 5-year Goodwill high stood at $2.1 million for Q2 2021, and its period low was $1.7 million during Q3 2022.
  • For the 3-year period, Summit Therapeutics' Goodwill averaged around $1.9 million, with its median value being $1.9 million (2023).
  • Per our database at Business Quant, Summit Therapeutics' Goodwill spiked by 614.25% in 2021 and then dropped by 17.29% in 2022.
  • Summit Therapeutics' Goodwill (Quarterly) stood at $2.0 million in 2021, then fell by 10.50% to $1.8 million in 2022, then climbed by 5.28% to $1.9 million in 2023, then decreased by 1.53% to $1.9 million in 2024, then climbed by 0.40% to $2.0 million in 2025.
  • Its Goodwill was $2.0 million in Q3 2025, compared to $2.0 million in Q2 2025 and $1.9 million in Q1 2025.